Cash-flush Piramal Enterprises Ltd., the flagship company of Indian pharma tycoon Ajay Pharma's Piramal Group, has taken another step toward its goal of being a top-three player in India’s over-the-counter business by buying four popular brands from Pfizer Inc. for INR1.1bn ($16.4m).
Piramal Enterprises, which holds a prominent position in health care and financial services, has been growing aggressively through acquisitions - a key element of its game plan to boost
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?